Jade Biosciences, Inc. Common Stock logo

Jade Biosciences, Inc. Common Stock

JBIO • NASDAQ

Jade Biosciences, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Tom Frohlich, with a market cap of $709.6M.

CEOTom Frohlich
Market Cap$709.6M
PHARMACEUTICAL PREPARATIONS
Websitejadebiosciences.com

Next Earnings

Upcoming earnings announcement for Jade Biosciences, Inc. Common Stock

Date
Friday, February 20, 2026 (in 1 week)
Timing
Before Market Open (4:04 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.46

Earnings History

Past 3 earnings reports for Jade Biosciences, Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Nov 13, 2025Q3 2025
-$0.48Est: -$0.63
+23.8%
-
—SEC10-Q
Aug 13, 2025Q2 2025
-$0.86Est: -$0.43
-100.0%
-
—SEC10-Q
May 14, 2025Q1 2025
-$12.10
—
-
——
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.